Why the study?
HFpEF has no effective treatments, and while mitochondrial fission dysfunctions occur, the relationship between PINK1, Drp1, and heart failure has not been clarified.
Does PINK1 overexpression improve mitochondrial fission and inhibit the progression of hypertension-induced HFpEF in animal models?
Does PINK1 overexpression improve mitochondrial fission and inhibit the progression of hypertension-induced HFpEF in animal models?
PINK1-mediated phosphorylation of Drp1S616 improves mitochondrial fission and slows the progression of hypertension-induced HFpEF in preclinical models, suggesting a potential therapeutic target.
May support PINK1-Drp1 modulation in HFpEF models; leaves open translation to human disease.
(1) Background: Heart failure with preserved ejection fraction (HFpEF) is a major subtype of HF with no effective treatments. Mitochondrial dysfunctions relevant to the imbalance of fusion and fission occur in HFpEF. Drp1 is a key protein regulating mitochondrial fission, and PINK1 is the upstream activator of Drp1, but their relationship with HF has not been clarified. The aim of the study is to investigate molecular mechanisms of mitochondrial dysfunctions in animals with hypertension-induced HFpEF. (2) Methods and Results: The hypertension-induced HFpEF model was established by feeding Dahl/SS rats with high salt, showing risk factors such as hypertension, mitochondrial dysfunctions, and so on. Physiological and biological measurements showed a decrease in the expression of mitochondrial function-related genes, ATP production, and mitochondrial fission index. PINK1 knockout in H9C2 cardiomyocytes showed similar effects. Moreover, PINK1 myocardium-specific overexpression activated Drp1S616 phosphorylation and enhanced mitochondrial fission to slow the progression of hypertension-induced HFpEF. (3) Conclusions: PINK1 could phosphorylate Drp1S616 to improve mitochondrial fission and relieve mitochondrial dysfunctions, which highlights potential treatments of HFpEF.
No takes yet. Share an insight, caveat, or question.
Shou et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: